Stefan Chmielewski

Head of Translational Immuno-oncology Research at Ryvu Therapeutics

Cracow Metropolitan Area

About

Experience

  • Ryvu Therapeutics (Full-time · 8 yrs 1 mo)
    • Head of Translational Immuno-oncology Research
      Oct 2019 - Present · 6 yrs 9 mos

      -Target deconvolution -Screening cascade design -Introduction and optimization of the assays enabling comprehensive compound characterization -Leading role in strategy for screening of potency, selectivity and efficacy -Leading role in biomarker strategy - selection, development and qualification of methods -Design and supervision of in vivo experiments allowing to provide in vivo proof of concept for tested compounds -Proposing and leading activities around MoA and responder hypothesis -Evaluation and interpretation of the experimental results of pre-clinical studies -Support of pre-clinical activities -Participation in development and qualification of clinical biomarkers

    • Project Manager
      Jun 2018 - Oct 2019 · 1 yr 5 mos

  • Selvita (4 yrs 4 mos)
    • Project Manager
      Jun 2018 - Oct 2019 · 1 yr 5 mos

    • Senior Scientist
      Jul 2015 - Oct 2019 · 4 yrs 4 mos

    • Team Leader, R&D Biology
      Oct 2015 - Jun 2018 · 2 yrs 9 mos

  • Wissenschaftlicher Mitarbeiter at Klinkum rechts der Isar
    Jan 2014 - Mar 2015 · 1 yr 3 mos

  • PhD Researcher at Technische Universität München
    Sep 2009 - Dec 2013 · 4 yrs 4 mos

    • Worked with experimental models of kidney and cardiovascular diseases such as hypertension, high fat diet-induced obesity, renal ischemia-reperfusion injury, abdominal aortic aneurysm formation. • Identified and evaluated novel targets of therapeutic intervention in cardiovascular disease • Prepared reports, posters and scientific publications • Trained new students

  • Researcher Master Thesis Project at Department of Human Molecular Genetics, Adam Mickiewicz University, Poland
    Sep 2007 - Aug 2009 · 2 yrs

    • Prepared theoretically and experimentally to conduct studies related to mechanism of signal transduction as well as gene expression regulation • Performed cloning and studied expression and DNA- binding activity of IRF transcription factors and their possible interaction with STAT1 and STAT2 in IFN signalling • Managed laboratory functions (organization, ordering and scheduling equipment use) • Trained new students